Cardiovascular disease - DiabetesontheNet

An audit of the “deadly trio” in GP practices in Birmingham

If sulphonylureas are more harmful than rosiglitazone, why has the latter been withdrawn, and the former has not?

Erectile dysfunction as a marker of CVD

Neuropathy – a predictor of cardiovascular disease?

ACCORD treatment resulted in microvascular benefit even in people with long-standing type 2 diabetes

Strong evidence for higher levels of fitness reducing the risk of diabetes

Aspirin for primary prevention of cardiovascular disease in people with diabetes: Yea or nay?

Cardiovascular risk: Managing dyslipidaemia in the context of diabetes

The final chapter in the rosiglitazone story

Rosiglitazone withdrawn: PCDS response

Managing diabetes in people with severe mental illness

Forget algorithms – treat all people with diabetes as being at high risk of CVD

Lowering blood pressure: Of any benefit in cardiovascular disease?

Diabetes – a coronary heart disease risk equivalent?

More clarity from ACCORD, or just more questions?

Cardiovascular risk: Managing hypertension in type 2 diabetes

CV risk factor control in type 2 diabetes – does ACCORD help?

Low-dose aspirin reduces CVD in people with type 2 diabetes